Summary of Purpose
The main purpose is to evaluate the effectiveness of the Eliquis® (apixaban) Prescriber Guide and Patient Alert Card in terms knowledge of the important identified risk of bleeding associated with Eliquis treatment communicated by the RM tools.Read More →
The following dates are available for this trial. Trial information last updated on 28 March 2016.
|1 Aug 2015||13 Jan 2015||1 Jan 2017||1 Jan 2017||1 Dec 2015||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Perspective: Cross-Sectional
- Sampling: Non-Probability Sample
- Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email:
- First line of the email MUST contain NCT# and Site #.